Vycor Medical Inc
VYCO· OTC
Released May 12, 2023, during market hours
10-Q filed May 12, 2023, 42 days after period end · 0001493152-23-016564
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $360.99K | $313.83K | $295.75K | $330.24K |
| Net Income | $6.86K | -$74.55K | -$242.92K | -$174.95K |
| EPS Diluted | $0.00 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| — |
| -$0.01 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.